Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Sep 5;17(1):342.
doi: 10.1186/s13023-022-02472-w.

Phenotypic expression of swallowing function in Niemann-Pick disease type C1

Beth I Solomon  1 , Andrea M Muñoz  2 , Ninet Sinaii  3 , Nicole M Farhat  2 , Andrew C Smith  2 , Simona Bianconi  2 , An Dang Do  2 , Michael C Backman  4 , Leonza Machielse  2 , Forbes D Porter  2
Affiliations
Observational Study

Phenotypic expression of swallowing function in Niemann-Pick disease type C1

Beth I Solomon et al. Orphanet J Rare Dis. .

Abstract

Background: Niemann-Pick disease type C1 (NPC1) is a rare autosomal recessive disease characterized by endolysosomal accumulation of unesterified cholesterol with progressive deterioration in swallowing, often leading to premature death. Although documented, the natural history of NPC1 swallowing dysfunction has yet to be delineated systematically. This manuscript aims to provide a comprehensive characterization of the phenotypic spectrum and progression of swallowing dysfunction in NPC1.

Methodology: The National Institutes of Health (NIH) NPC1 natural history study (NCT00344331) enrolled 120 patients, who underwent comprehensive interpretative swallow assessments for swallowing safety, dietary modifications, and aspiration risk. Longitudinal statistical modeling accounted for all outcomes with NPC1 disease covariates (first symptom onset, age at neurological symptom onset, seizure history, duration of neurological symptoms) as well as miglustat use (a glucosylceramide synthase inhibitor) and NIH study duration (NIHSD; the length of time an individual participated in the NIH study). Probabilities for disease progression and time to swallowing decline were conducted for the entire cohort.

Results: Time to swallowing decline with American Speech-Language-Hearing Association National Outcome Measure (ASHA-NOMS) and the NIH-adapted Penetration Aspiration Scale (NIH-PAS) were identified: [Formula: see text] person-years and [Formula: see text] person-years, respectively. NIHSD and seizure history consistently and significantly were associated with decline (ORNIHSD = 1.34-2.10, 95% CI 1.04-3.4, p = 0.001-0.026; ORSeizure = 3.26-18.22, 1.03-167.79; p = 0.001-0.046), while miglustat use revealed protection (ORMiglustat = 0.01-0.43, 0.007-0.98; p = 0.001-0.044). The probability of decline with NPC1 neurological severity scale and annual severity increment scale were established with the aforementioned covariates, varying amongst subgroups.

Conclusion: This study represents the most extensive collection of prospective, instrumental swallowing assessments in NPC1 to date with an interpretive analysis providing an improved understanding of NPC1 disease progression with swallowing function-serving as a foundation for clinical management and future NPC1 therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
CONSORT diagram of patient enrollment in National Institutes of Health Niemann–Pick disease Type C1 (NPC1) natural history study (NCT00344331)
Fig. 2
Fig. 2
Niemann–Pick disease Type C1 (NPC1) time to swallowing decline survival plots for the American Speech-Language-Hearing Association National Outcome Measures Scale (ASHA-NOMS) and the NIH-Adapted Rosenbek Penetration and Aspiration Scale (NIH-PAS)
Fig. 3
Fig. 3
Forest plots of longitudinal analysis results of all outcomes in patients with Niemann–Pick disease Type C1
See this image and copyright information in PMC

References

    1. Wassif CA, Cross JL, Iben J, et al. High incidence of unrecognized visceral/neurological late-onset Niemann–Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med. 2016;18(1):41–48. doi: 10.1038/gim.2015.25. - DOI - PMC - PubMed
    1. Ory DS. Niemann–Pick type C: a disorder of cellular cholesterol trafficking. Biochim Biophys Acta. 2000;1529(1–3):331–339. doi: 10.1016/s1388-1981(00)00158-x. - DOI - PubMed
    1. Vanier MT. Niemann–Pick disease type C. Orphanet J Rare Dis. 2010;5:16. doi: 10.1186/1750-1172-5-16. - DOI - PMC - PubMed
    1. Walterfang M, Chien YH, Imrie J, Rushton D, Schubiger D, Patterson MC. Dysphagia as a risk factor for mortality in Niemann–Pick disease type C: systematic literature review and evidence from studies with miglustat. Orphanet J Rare Dis. 2012;7:76. doi: 10.1186/1750-1172-7-76. - DOI - PMC - PubMed
    1. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996;11(2):93–98. doi: 10.1007/bf00417897. - DOI - PubMed

Publication types

Substances

Associated data